Huntington's Disease ▲ https://phgkb.cdc.gov/GAPPKB/phgHome.do | NEW TOPIC PAGE

https://phgkb.cdc.gov/GAPPKB/phgHome.do




Last Posted: Jul 07, 2016

---

• ETHICAL AND GENETIC ASPECTS REGARDING PRESYMPTOMATIC TESTING FOR NEURODEGENERATIVE DISEASES.  
  Rev Med Chir Soc Med Nat Iasi. 2016 Jan-Mar;120(1):15-22.
• Personal utility in genomic testing: is there such a thing?  
  Bunnik Eline M et al. Journal of medical ethics 2015 Apr 41(4) 322-6
• Huntington’s disease: the new gene therapy that sufferers cannot afford,  
  by Dara Mohammadi, the Guardian, May 15, 2016
• Low utilization of prenatal and pre-implantation genetic diagnosis in Huntington disease - risk discounting in preventive genetics.  
  Schulman J D et al. Clinical genetics 2015 Sep 88(3) 220-3
• Development of a community-based exercise program for people diagnosed and at-risk for Huntington's disease: A clinical report.  
  Clark Dalie et al. Physiotherapy theory and practice 2016 Apr 1-8
• Clinical and genetic data of Huntington disease in Moroccan patients.  
  Bouhouche Ahmed et al. African health sciences 2015 Dec 15(4) 1232-8
• Daughter shares the same Huntington’s disease gene which killed her late father,  
  by Jane Hansen, the Daily Telegraph, March 12, 2016
• Do you really want to know your medical future?  
  M. Dahl, CNN, March 8, 2016
• Current status of PET imaging in Huntington's disease.  
  Pagano Gennaro et al. European journal of nuclear medicine and molecular imaging 2016 Feb
• Neuropsychiatric symptoms are very common in premanifest and early stage Huntington's Disease.  
  Martinez-Horta Saul et al. Parkinsonism & related disorders 2016 Feb
• Pridopidine for the treatment of Huntington's disease.  
  Shannon Kathleen M et al. Expert opinion on investigational drugs 2016 Feb
• The Frequency of Huntington Disease and Huntington Disease-Like 2 in the South African Population.  
  Baine Fiona K et al. Neuroepidemiology 2016 Feb (3) 198-202
• Huntington Disease Update  
  R Lewis, PLOS Blogs, February 29, 2016
• Huntington's disease patients get first dosing in historic Isis Pharmaceuticals’ gene-silencing drug trial,  
  at Risk for Huntington's Disease Blog, October 19, 2015
• Genetic Counselling for Predictive Testing in Huntington's Disease in One Centre since 1993. Gender-Specific Aspects of Decision-Making.  
  Arning Larissa et al. J Huntingtons Dis 2015 4(1) 87-98
• Guidelines for presymptomatic testing for Huntington's disease: Past, present and future in France.  
  Clément S et al. Rev. Neurol. (Paris) 2015 May 19.